Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Epristeride. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111362999B details a novel oxidation method for Epristeride impurity. This report analyzes cost reduction in API manufacturing and high-purity reference standard production.
Novel palladium-catalyzed method for Epristeride ensures high purity and scalable production for pharmaceutical supply chains reducing costs significantly and improving safety